Search Results - "Andres Duarte-Rojo"

Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice by Lai, Jennifer C., Sonnenday, Christopher J., Tapper, Elliot B., Duarte‐Rojo, Andres, Dunn, Michael A., Bernal, William, Carey, Elizabeth J., Dasarathy, Srinivasan, Kamath, Binita M., Kappus, Matthew R., Montano‐Loza, Aldo J., Nagai, Shunji, Tandon, Puneeta

“…Frailty has emerged as a powerful predictor of outcomes in patients with cirrhosis and has inevitably made its way into decision making within liver…”
Get full text

Feasibility and diagnostic performance of the FibroScan XL probe for liver stiffness measurement in overweight and obese patients by Myers, Robert P., Pomier-Layrargues, Gilles, Kirsch, Richard, Pollett, Aaron, Duarte-Rojo, Andres, Wong, David, Beaton, Melanie, Levstik, Mark, Crotty, Pam, Elkashab, Magdy

“…Failure of liver stiffness measurement (LSM) by transient elastography (TE, FibroScan) and unreliable results occur in ≈5% and 15% of patients, respectively,…”
Get full text

Physical Function, Physical Activity, and Quality of Life After Liver Transplantation by Dunn, Michael A., Rogal, Shari S., Duarte‐Rojo, Andres, Lai, Jennifer C.

“…Robust physical activity after liver transplantation is an important determinant of longterm health, similar in its importance to the value of pretransplant…”
Get full text

A North American Expert Opinion Statement on Sarcopenia in Liver Transplantation by Carey, Elizabeth J., Lai, Jennifer C., Sonnenday, Christopher, Tapper, Elliot B., Tandon, Puneeta, Duarte‐Rojo, Andres, Dunn, Michael A., Tsien, Cynthia, Kallwitz, Eric R., Ng, Vicky, Dasarathy, Srinivasan, Kappus, Matthew, Bashir, Mustafa R., Montano‐Loza, Aldo J.

“…Loss of muscle mass and function, or sarcopenia, is a common feature of cirrhosis and contributes significantly to morbidity and mortality in this population…”
Get full text

Exercise and physical activity for patients with end‐stage liver disease: Improving functional status and sarcopenia while on the transplant waiting list by Duarte‐Rojo, Andrés, Ruiz‐Margáin, Astrid, Montaño‐Loza, Aldo J., Macías‐Rodríguez, Ricardo U., Ferrando, Arny, Kim, W. Ray

“…Sarcopenia and physical deconditioning are frequent complications in patients with cirrhosis and end‐stage liver disease (ESLD). They are the end result of…”
Get full text

Extracorporeal cellular therapy (ELAD) in severe alcoholic hepatitis: A multinational, prospective, controlled, randomized trial by Thompson, Julie, Jones, Natasha, Al‐Khafaji, Ali, Malik, Shahid, Reich, David, Munoz, Santiago, MacNicholas, Ross, Hassanein, Tarek, Teperman, Lewis, Stein, Lance, Duarte‐Rojo, Andrés, Malik, Raza, Adhami, Talal, Asrani, Sumeet, Shah, Nikunj, Gaglio, Paul, Duddempudi, Anupama, Borg, Brian, Jalan, Rajiv, Brown, Robert, Patton, Heather, Satoskar, Rohit, Rossi, Simona, Parikh, Amay, ElSharkawy, Ahmed, Mantry, Parvez, Sher, Linda, Wolf, David, Hart, Marquis, Landis, Charles, Wigg, Alan, Habib, Shahid, McCaughan, Geoffrey, Colquhoun, Steven, Henry, Alyssa, Bedard, Patricia, Landeen, Lee, Millis, Michael, Ashley, Robert, Frank, William, Henry, Andrew, Stange, Jan, Subramanian, Ram

“…Severe alcoholic hepatitis (sAH) is associated with a poor prognosis. There is no proven effective treatment for sAH, which is why early transplantation has…”
Get full text

Report from the American Society of Transplantation on frailty in solid organ transplantation by Kobashigawa, Jon, Dadhania, Darshana, Bhorade, Sangeeta, Adey, Deborah, Berger, Joseph, Bhat, Geetha, Budev, Marie, Duarte‐Rojo, Andres, Dunn, Michael, Hall, Shelley, Harhay, Meera N., Johansen, Kirsten L., Joseph, Susan, Kennedy, Cassie C., Kransdorf, Evan, Lentine, Krista L., Lynch, Raymond J., McAdams‐DeMarco, Mara, Nagai, Shunji, Olymbios, Michael, Patel, Jignesh, Pinney, Sean, Schaenman, Joanna, Segev, Dorry L., Shah, Palak, Singer, Lianne G., Singer, Jonathan P., Sonnenday, Christopher, Tandon, Puneeta, Tapper, Elliot, Tullius, Stefan G., Wilson, Michael, Zamora, Martin, Lai, Jennifer C.

“…A consensus conference on frailty in kidney, liver, heart, and lung transplantation sponsored by the American Society of Transplantation (AST) and endorsed by…”
Get full text

Frailty, mortality, and health care utilization after liver transplantation: From the Multicenter Functional Assessment in Liver Transplantation (FrAILT) Study by Lai, Jennifer C., Shui, Amy M., Duarte‐Rojo, Andres, Ganger, Daniel R., Rahimi, Robert S., Huang, Chiung‐Yu, Yao, Frederick, Kappus, Matthew, Boyarsky, Brian, McAdams‐Demarco, Mara, Volk, Michael L., Dunn, Michael A., Ladner, Daniela P., Segev, Dorry L., Verna, Elizabeth C., Feng, Sandy

“…Background and Aims Frailty is a well‐established risk factor for poor outcomes in patients with cirrhosis awaiting liver transplantation (LT), but whether it…”
Get full text

Improving the fitness of the NASH clinical trial: Standardizing the standard‐of‐care intervention by Kappus, Matthew R., Patel, Yuval A., Duarte‐Rojo, Andres

Get full text

Identifying an Optimal Liver Frailty Index Cutoff to Predict Waitlist Mortality in Liver Transplant Candidates by Kardashian, Ani, Ge, Jin, McCulloch, Charles E., Kappus, Matthew R., Dunn, Michael A., Duarte‐Rojo, Andres, Volk, Michael L., Rahimi, Robert S., Verna, Elizabeth C., Ganger, Daniel R., Ladner, Daniela, Dodge, Jennifer L., Boyarsky, Brian, McAdams‐DeMarco, Mara, Segev, Dorry L., Lai, Jennifer C.

“…Background and Aims Frailty, as measured by the Liver Frailty Index (LFI), is associated with liver transplant (LT) waitlist mortality. We sought to identify…”
Get full text

Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography by Myers, Robert P., Pollett, Aaron, Kirsch, Richard, Pomier-Layrargues, Gilles, Beaton, Melanie, Levstik, Mark, Duarte-Rojo, Andres, Wong, David, Crotty, Pam, Elkashab, Magdy

“…Background Accurate tools for the noninvasive detection of hepatic steatosis are needed. The Controlled Attenuation Parameter (CAP) specifically targets liver…”
Get full text

Cadence From Physical Activity Trackers for Monitoring of Home‐Based Exercise Intensity in Advanced Liver Disease by Chen, Hui Wei, Ferrando, Arny A., Dunn, Michael A., Kim, W. Ray, Duarte‐Rojo, Andrés

Get full text

Inpatient Frailty Assessment Is Feasible and Predicts Nonhome Discharge and Mortality in Decompensated Cirrhosis by Serper, Marina, Tao, Sunny Y., Kent, Dorothea S., Garren, Patrik, Burdzy, Alexander E., Lai, Jennifer C., Gougol, Amir, Bloomer, Pamela M., Reddy, K. Rajender, Dunn, Michael A., Duarte‐Rojo, Andres

“…Objective inpatient frailty assessments in decompensated cirrhosis are understudied. We examined the feasibility of inpatient frailty measurements and…”
Get full text

Exercise‐Induced Hyperammonemia Does Not Precipitate Overt Hepatic Encephalopathy by Lin, Fei‐Pi, Ferrando, Arny A., Dennis, Richard A., Dunn, Michael A., Kim, W. Ray, Duarte‐Rojo, Andrés

Get full text

The relationship between frailty and cirrhosis etiology: From the Functional Assessment in Liver Transplantation (FrAILT) Study by Xu, Chelsea Q., Mohamad, Yara, Kappus, Matthew R., Boyarsky, Brian, Ganger, Daniel R., Volk, Michael L., Rahimi, Robert S., Duarte‐Rojo, Andres, McAdams‐DeMarco, Mara, Segev, Dorry L., Ladner, Daniela P., Verna, Elizabeth C., Grab, Joshua, Tincopa, Monica, Dunn, Michael A., Lai, Jennifer C.

“…Background & Aims Cirrhosis leads to malnutrition and muscle wasting that manifests as frailty, which may be influenced by cirrhosis aetiology. We aimed to…”
Get full text

Changes in Hepatic Venous Pressure Gradient Induced by Physical Exercise in Cirrhosis: Results of a Pilot Randomized Open Clinical Trial by Macías-Rodríguez, Ricardo U, Ilarraza-Lomelí, Hermes, Ruiz-Margáin, Astrid, Ponce-de-León-Rosales, Sergio, Vargas-Vorácková, Florencia, García-Flores, Octavio, Torre, Aldo, Duarte-Rojo, Andrés

“…Exercise has been scarcely studied in patients with cirrhosis, and prior evidence showed hepatic venous pressure gradient (HVPG) to be increased in response to…”
Get full text

Clinical scenarios for the use of S100β as a marker of hepatic encephalopathy by Duarte-Rojo, Andrés, Ruiz-Margáin, Astrid, Macias-Rodriguez, Ricardo U, Cubero, Francisco Javier, Estradas-Trujillo, José, Muñoz-Fuentes, Rosa Ma, Torre, Aldo

“…AIM: To evaluate the association between serum concentrations of S100β in patients with cirrhosis and the presence of low grade hepatic…”
Get full text

Frailty and the Risk of Acute Kidney Injury Among Patients With Cirrhosis by Cullaro, Giuseppe, Verna, Elizabeth C., Duarte‐Rojo, Andres, Kappus, Matthew R., Ganger, Daniel R., Rahimi, Robert S., Boyarsky, Brian, Segev, Dorry L., McAdams‐DeMarco, Mara, Ladner, Daniela P., Volk, Michael L., Hsu, Chi‐yuan, Lai, Jennifer C.

“…Acute kidney injury (AKI) and frailty are major drivers of outcomes among patients with cirrhosis. What is unknown is the impact of physical frailty on the…”
Get full text

Noninvasive markers of fibrosis: key concepts for improving accuracy in daily clinical practice by Duarte-Rojo, Andrés, Altamirano, José Trinidad, Feld, Jordan J

“…Noninvasive markers of fibrosis have emerged as an alternative to the staging of fibrosis by means of liver biopsy. Apart from being noninvasive and thus…”
Get full text

Cognitive Impairment and Physical Frailty in Patients With Cirrhosis by Berry, Kacey, Duarte‐Rojo, Andres, Grab, Joshua D., Dunn, Michael A., Boyarsky, Brian J., Verna, Elizabeth C., Kappus, Matthew R., Volk, Michael L., McAdams‐DeMarco, Mara, Segev, Dorry L., Ganger, Daniel R., Ladner, Daniela P., Shui, Amy, Tincopa, Monica A., Rahimi, Robert S., Lai, Jennifer C.

“…Physical frailty and impaired cognition are common in patients with cirrhosis. Physical frailty can be assessed using performance‐based tests, but the extent…”
Get full text